Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines
Study sponsor: Novavax
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-11-11Actual
Enrollment · participants147Actual
Source updated2025-06-26Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.